single invest

ImmuMap

ImmuMap is dedicated to advancing the use and quality of flow cytometry-based monitoring of cellular immunity. They deliver cellular immunological mode-of-action analyses based on advanced flow cytometry, ELISpot, and cell culturing including unique high-end multiplex assays.

 

ImmuMap has been a part of the Accelerace accelerator program, that help startup companies accelerate and scale up their business model and finetune their companies. ImmuMap is one of more than 500 companies that Accelerace already have accelerated.


Related startups


EdgeFlow